loading
Precedente Chiudi:
$0.0002
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$N/A
Reddito:
$675.00K
Utile/perdita netta:
$-34.63M
Rapporto P/E:
0.00
EPS:
-13.3158
Flusso di cassa netto:
$-29.28M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-99.78%
Intervallo 1D:
Value
$0.00
$0.00
Intervallo di 1 settimana:
Value
$0.00
$0.00
Portata 52W:
Value
$0.00
$0.0002

Effector Therapeutics Inc Stock (EFTR) Company Profile

Name
Nome
Effector Therapeutics Inc
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
EFTR's Discussions on Twitter

Compare EFTR vs VRTX, REGN, ARGX, ALNY, ONC

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
EFTR
Effector Therapeutics Inc
0.00 0 675.00K -34.63M -29.28M -13.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.34 119.23B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
745.77 78.84B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
700.45 43.35B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
313.41 41.57B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
284.05 31.51B 5.36B 287.73M 924.18M 2.5229

Effector Therapeutics Inc Stock (EFTR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-01-25 Downgrade Stifel Buy → Hold
2021-11-09 Aggiornamento Stifel Hold → Buy
2021-10-12 Iniziato Credit Suisse Outperform
2021-10-04 Iniziato Mizuho Buy
2021-09-21 Iniziato JMP Securities Mkt Outperform
2021-09-20 Iniziato Stifel Hold
2021-09-13 Iniziato Cantor Fitzgerald Overweight
Mostra tutto

Effector Therapeutics Inc Borsa (EFTR) Ultime notizie

pulisher
Mar 03, 2026

EFTR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 03, 2026
pulisher
Mar 01, 2026

CapEx per share of eFFECTOR Therapeutics Inc – MUN:LWK - TradingView

Mar 01, 2026
pulisher
Feb 28, 2026

Stock List: Research Stocks from Around the World - GuruFocus

Feb 28, 2026
pulisher
Feb 27, 2026

MBX Biosciences, Inc. Announces CFO Changes - marketscreener.com

Feb 27, 2026
pulisher
Feb 20, 2026

Reprogramming The Tumor Microenvironment Bringing A Metabolic Checkpoint Therapy Into The Clinic - Clinical Leader

Feb 20, 2026
pulisher
Feb 16, 2026

Head-To-Head Comparison: eFFECTOR Therapeutics (NASDAQ:EFTR) & Bio-Path (NASDAQ:BPTH) - Defense World

Feb 16, 2026
pulisher
Feb 15, 2026

ZIMCF Stock Price, News & Analysis - Stock Titan

Feb 15, 2026
pulisher
Jan 15, 2026

Indian American Premal Patel joins Elephas Biosciences as CMO - The American Bazaar

Jan 15, 2026
pulisher
Jan 15, 2026

Non-covid mRNA Vaccine and Therapeutics Market Exclusive Report on the Latest Revenue and Future Scope - openPR.com

Jan 15, 2026
pulisher
Jan 09, 2026

Head to Head Analysis: Hepion Pharmaceuticals (NASDAQ:HEPA) versus eFFECTOR Therapeutics (NASDAQ:EFTR) - Defense World

Jan 09, 2026
pulisher
Jan 09, 2026

Barclays Forecasts Strong Price Appreciation for Lloyds Banking Group (LON:LLOY) Stock - Defense World

Jan 09, 2026
pulisher
Jan 09, 2026

Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

Jan 09, 2026
pulisher
Jan 08, 2026

Is eFFECTOR Therapeutics Inc. (LWK) stock undervalued at current price2025 Historical Comparison & Capital Protection Trade Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Is eFFECTOR Therapeutics Inc. (LWK) stock expanding market penetrationTrade Analysis Summary & High Yield Stock Recommendations - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

ELEPHAS BIOSCIENCES STRENGTHENS SCIENTIFIC AND CLINICAL LEADERSHIP AS COMPANY ADVANCES TOWARD COMMERCIAL AVAILABILITY OF ITS LIVE-TUMOR IMMUNOLOGY PLATFORM - Morningstar

Jan 08, 2026
pulisher
Jan 07, 2026

WeRide (NASDAQ:WRD) Now Covered by Analysts at CLSA - Defense World

Jan 07, 2026
pulisher
Jan 06, 2026

PowerFleet (NASDAQ:AIOT) Given Outperform Rating at Barrington Research - Defense World

Jan 06, 2026
pulisher
Jan 03, 2026

Big Rock Brewery (TSE:BR) Shares Cross Below 50 Day Moving Average – What’s Next? - Defense World

Jan 03, 2026
pulisher
Dec 24, 2025

eFFECTOR Therapeutics (NASDAQ:EFTR) and Synaptogenix (NASDAQ:TAOX) Head to Head Review - Defense World

Dec 24, 2025
pulisher
Dec 19, 2025

Can eFFECTOR Therapeutics Inc. (LWK) stock expand revenue streamsTrade Entry Report & Weekly Watchlist for Consistent Profits - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Is eFFECTOR Therapeutics Inc. (LWK) stock vulnerable to rate hikesTrade Volume Report & Stock Market Timing Techniques - DonanımHaber

Dec 19, 2025
pulisher
Dec 15, 2025

PD-1 and PD-L1 Inhibitors Market expected to Witness Huge Revenue Growth to 2034 - openPR.com

Dec 15, 2025
pulisher
Dec 05, 2025

Why eFFECTOR Therapeutics Inc. (LWK) stock gets analyst attentionInsider Buying & AI Enhanced Trading Signals - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Is eFFECTOR Therapeutics Inc. (LWK) stock positioned for secular growth2025 Market Outlook & Long Hold Capital Preservation Tips - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Why eFFECTOR Therapeutics Inc. (LWK) stock remains top ratedWeekly Stock Recap & Daily Profit Maximizing Tips - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Is eFFECTOR Therapeutics Inc. (LWK) stock resilient in recession scenariosMarket Performance Summary & Risk Controlled Swing Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Why eFFECTOR Therapeutics Inc. (LWK) stock is listed among top recommendations2025 Technical Patterns & Risk Managed Investment Signals - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

What consensus target says about eFFECTOR Therapeutics Inc. (LWK) stockJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

How dovish Fed policy supports eFFECTOR Therapeutics Inc. (LWK) stockJuly 2025 Sector Moves & Stock Portfolio Risk Management - Newser

Dec 02, 2025
pulisher
Nov 26, 2025

eFFECTOR Therapeutics, Inc. (EFTR) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Nov 26, 2025
pulisher
Nov 22, 2025

eFFECTOR Therapeutics, Inc. (EFTR) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Nov 22, 2025
pulisher
Nov 21, 2025

How eFFECTOR Therapeutics Inc. (LWK) stock gains from tech spending2025 Short Interest & Fast Gaining Stock Reports - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Wall Street indexes jump as bets on rate cut increase, Nvidia gains on report - marketscreener.com

Nov 21, 2025
pulisher
Nov 21, 2025

eFFECTOR Therapeutics (NASDAQ:EFTR) versus Evotec (OTCMKTS:EVTCY) Head to Head Review - Defense World

Nov 21, 2025
pulisher
Nov 20, 2025

Major corporations shift listings to Nasdaq amid growing tech focus - marketscreener.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why eFFECTOR Therapeutics Inc. (LWK) stock attracts wealthy investorsAnalyst Downgrade & Safe Capital Preservation Plans - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Will eFFECTOR Therapeutics Inc. (LWK) stock justify high valuationJuly 2025 Weekly Recap & Technical Pattern Based Buy Signals - newser.com

Nov 19, 2025

Effector Therapeutics Inc Azioni (EFTR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):